71
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model

, , &
Pages 284-289 | Received 10 Nov 2017, Accepted 01 Mar 2018, Published online: 05 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Seyed Shahabeddin Mortazavi-Jahromi, Arman Ahmadzadeh, Zahra Rezaieyazdi, Mona Aslani, Saiedeh Omidian & Abbas Mirshafiey. (2020) The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients. Immunopharmacology and Immunotoxicology 42:3, pages 228-236.
Read now

Articles from other publishers (3)

Xing Lv, Huijun Wang, Ruoming Wu, Xiaoyan Shen & Guan Ye. (2020) The Active Compounds of Yixin Ningshen Tablet and Their Potential Action Mechanism in Treating Coronary Heart Disease- A Network Pharmacology and Proteomics Approach. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-17.
Crossref
Alireza Rezaeinezhad, Pegah Eslami, Hossein Mirmiranpour & Hamid Ghomi. (2019) The effect of cold atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, and inflammation; in vitro and in vivo. Scientific Reports 9:1.
Crossref
Zahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, Arman Ahmadzadeh, Mona Aslani, Saiedeh Omidian, Arezoo Sadoughi, Zohreh Vahidi, Mandana Khodashahi, Shazia Zamurrad, Seyed Shahabeddin Mortazavi-Jahromi, Hossein Fallahzadeh, Mostafa Hosseini, Zahra Aghazadeh, Parvin Ekhtiari, Hidenori Matsuo, Bernd H. A. Rehm, Salvatore Cuzzocrea, Antimo D’Aniello & Abbas Mirshafiey. (2019) International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology 27:5, pages 911-921.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.